Phibro Animal Health Corporation (NASDAQ:PAHC) VP Daniel M. Bendheim sold 300 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $40.08, for a total value of $12,024.00. Following the completion of the transaction, the vice president now directly owns 300 shares in the company, valued at $12,024. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.50% on Wednesday, hitting $40.00. The stock had a trading volume of 55,178 shares. The firm has a market capitalization of $1.59 billion, a P/E ratio of 24.84 and a beta of 1.35. The company has a 50 day moving average of $38.23 and a 200-day moving average of $32.54. Phibro Animal Health Corporation has a 12-month low of $20.14 and a 12-month high of $40.25.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be given a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a yield of 1.00%. Phibro Animal Health Corporation’s dividend payout ratio is currently 24.69%.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/16/phibro-animal-health-corporation-pahc-vp-daniel-m-bendheim-sells-300-shares.html.

A number of hedge funds have recently modified their holdings of the stock. State of Alaska Department of Revenue raised its stake in shares of Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock worth $136,000 after buying an additional 1,650 shares in the last quarter. Mason Street Advisors LLC raised its stake in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its stake in shares of Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after buying an additional 150 shares in the last quarter. KBC Group NV bought a new stake in shares of Phibro Animal Health Corporation during the second quarter worth $166,000. Finally, Victory Capital Management Inc. raised its stake in shares of Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares in the last quarter. Hedge funds and other institutional investors own 47.64% of the company’s stock.

Several research analysts have recently commented on the company. Piper Jaffray Companies set a $35.00 target price on Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. BidaskClub raised Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 22nd. Credit Suisse Group downgraded Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Finally, Zacks Investment Research raised Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a report on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $30.50.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.